Altered ganglioside GD3 in HeLa cells might influence the cytotoxic abilities of NK cells

Taiwanese Journal of Obstetrics and Gynecology

Volumn 51, Issue 2, 2012, Pages 199-205

  Lee, Wen Chi ^a,b   Lee, Wen Ling ^c,d   Shyong, Wen Yuann ^a,b   Yang, Lin Wei ^a,b   Ko, Min Chun ^a,b   Yeh, Chang Ching ^a,b   Edmond Hsieh, Shie Liang ^a,b   Wang, Peng Hui ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Cervical cancer; Cytotoxicity; Gangliosides; Natural killer cells; Sialidases

Indexed keywords

GANGLIOSIDE GD3; SIALIDASE; SIALIDASE INHIBITOR;

ARTICLE; CYTOTOXICITY; FEMALE; GLYCOSYLATION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; UPREGULATION;

COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; GANGLIOSIDES; HELA CELLS; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; NEURAMINIDASE; SUGAR ACIDS; UP-REGULATION;

EID: 84863866502     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2012.04.006     Document Type: Article

References (38)

1. Sun H.D., Lai C.R., Yen M.S., Wang P.H. Synchronous occurrence of primary neoplasms of the uterus with mucinous carcinoma of the cervix and endometrioid carcinoma of the endometrium. Taiwan J Obstet Gynecol 2011, 50:377-378.
2. Orleans-Lindsay J.K., Barber L.D., Prentice H.G., Lowdell M.W. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function-implications for the adoptive immunotherapy of leukaemia. Clin Exp Immunol 2001, 126:403-411.
3. Bennett M.W., O'Connell J., O'Sullivan G.C., Brady C., Roche D., Collins J.K., et al. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 1998, 160:5669-5675.
4. Matsuda M., Petersson M., Lenkei R., Taupin J.L., Magnusson I., Mellstedt H., et al. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 1995, 61:765-772.
5. Waldhauer I., Steinle A. NK cells and cancer immunosurveillance. Oncogene 2008, 27:5932-5943.
6. Imai K., Matsuyama S., Miyake S., Suga K., Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000, 356:1795-1799.
7. Mocchegiani E., Ciavattini A., Santarelli L., Tibaldi A., Muzzioli M., Bonazzi P., et al. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma. Br J Cancer 1999, 79:244-250.
8. Garcia-Iglesias T., Del Toro-Arreola A., Albarran-Somoza B., Del Toro-Arreola S., Sanchez-Hernandez P.E. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 2009, 9:186.
9. Sutlu T., Alici E. Natural killer cell-based immunotherapy in cancer: current insights and future prospects. J Intern Med 2009, 266:154-181.
10. Furukawa K., Hamamura K., Nakashima H. Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomas. Proteomics 2008, 8:3312-3316.
11. Bergelson L.D., Dyatlovitskaya E.V., Klyuchareva T.E., Kryukova E.V., Lemenovskaya A.F., Matveeva V.A., et al. The role of glycosphingolipids in natural immunity: gangliosides modulate the cytotoxicity of natural killer cells. Eur J Immunol 1989, 19:1979-1983.
12. Grayson G., Ladisch S. Immunosuppression by human gangliosides, II: carbohydrate structure and inhibition of human NK activity. Cell Immunol 1992, 139:18-29.
13. Welt S., Carswell E.A., Vogel C.W., Oettgen H.F., Old L.J. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells. Clin Immunol Immunopathol 1987, 45:214-229.
14. Nasi M.L., Meyers M., Livingston P.O., Houghton A.N., Chapman P.B. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside. Melanoma Res 1997, 7(Suppl. 2):S155-S162.
15. Hsu C.C., Lin T.W., Chang W.W., Wu C.Y., Lo W.H., Wang P.H., et al. Soyasaponin-I modified invasive behavior of cancer by changing cell surface sialicacids. Gynecol Oncol 2005, 96:415-422.
16. Chang W.W., Yu C.Y., Lin T.W., Wang P.H., Tsai Y.C. Soyasaponin I decreases the expression of α2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells. Biochem Biophys Res Commun 2006, 341:614-619.
17. Schauer R. Sialic acids: fascinating sugars in higher animals and man. Zoology (Jena) 2004, 107:49-64.
18. Miyagi T. Aberrant expression of sialidase and cancer progression. Proc Jpn Acad Ser B Phys Biol Sci 2008, 84:407-418.
19. Hata K., Koseki K., Yamaguchi K., Moriya S., Suzuki Y., Yingsakmongkon S., et al. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother 2008, 52:3484-3491.
20. Nan X., Carubelli I., Stamatos N.M. Sialidase expression in activated human T lymphocytes influences production of IFN-gamma. J Leukoc Biol 2007, 81:284-296.
21. Miyagi T., Wada T., Yamaguchi K., Hata K. Sialidase and malignancy: a minireview. Glycoconj J 2004, 20:189-198.
22. Miyagi T., Wada T., Yamaguchi K. Roles of plasma membrane-associated sialidase NEU3 in human cancers. Biochim Biophys Acta 2008, 1780:532-537.
23. Nicoll G., Avril T., Lock K., Furukawa K., Bovin N., Crocker P.R. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur J Immunol 2003, 33:1642-1648.
24. Moebius J.M., Widera D., Schmitz J., Kaltschmidt C., Piechaczek C. Impact of polysialylated CD56 on natural killer cell cytotoxicity. BMC Immunol 2007, 8:13.
25. Lee WC, Lee WL, Shyong WY, Yang LW, Ko MC, Sheu BC. Increasing sialidases in the HeLa cells might influence cytotoxic ability of NK cells. Taiwan J Obstet Gynecol, in this issue.
26. Weng S.L., Chang S.J., Cheng Y.C., Wang H.Y., Wang T.Y., Chang M.D.T., et al. Comparative transcriptomeanalysis reveals a fetal origin for mesenchymal stem cells and novel fetal surface antigens for noninvasive prenatal diagnosis. Taiwan J Obstet Gynecol 2011, 50:447-457.
27. Munz C., Dao T., Ferlazzo G., de Cos M.A., Goodman K., Young J.W. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 2005, 105:266-273.
28. Saito M., Hagita H., Iwabuchi Y., Fujii I., Ikeda K., Ito M. Fluorescent cytochemical detection of sialidase activity using 5-bromo-4-chloroindol-3-yl-α-D-N-acetylneuraminic acid as the substrate. Histochem Cell Biol 2002, 117:453-458.
29. Suzuki T., Takahashi T., Guo C.T., Hidari K.I., Miyamoto D., Goto H., et al. Sialidase activity of Influenza A virus in an endocytic pathway enhances viral replication. J Virol 2005, 79:11705-11715.
30. Tsui K.H., Wang P.H., Chen C.K., Chen Y.J., Chiou S.H., Sung Y.J., et al. Non-classical estrogen receptors action on human dermal fibroblasts. Taiwan J Obstet Gynecol 2011, 50:474-478.
31. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
32. Newman K.C., Riley E.M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007, 7:279-291.
33. Lanier L.L. Natural killer cell receptor signaling. Curr Opin Immunol 2003, 15:308-314.
34. Loose D., Van de Wiele C. The immune system and cancer. Cancer Biother Radiopharm 2009, 24:369-376.
35. Menetrier-Caux C., Montmain G., Dieu M.C., Bain C., Favrot M.C., Caux C., et al. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998, 92:4778-4791.
36. Duluc D., Delneste Y., Tan F., Moles M.P., Grimaud L., Lenoir J., et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007, 110:4319-4330.
37. Agarwal A., Rani M., Saha G.K., Valarmathi T.M., Bahadur S., Mohanti B.K., et al. Disregulated expression of the Th2 cytokines gene in patients with intraoral squamous cell carcinoma. Immunol Invest 2003, 32:17-30.
38. Jarnicki A.G., Lysaght J., Todryk S., Mills K.H. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 2006, 177:896-904.